[212Pb] VMT-α-NET
202206110
Phase 1 small_molecule active
Quick answer
[212Pb] VMT-α-NET for Neuroendocrine Tumors is a Phase 1 program (small_molecule) at Perspective Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Perspective Therapeutics
- Indication
- Neuroendocrine Tumors
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active